International Biotechnology Trust plc
IBT.L · LSE
8/31/2025 | 2/28/2025 | 8/31/2024 | 2/29/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.26 | -0.10 | -0.01 |
| FCF Yield | 0.00% | -1.18% | -13.50% | 9.61% |
| EV / EBITDA | -1.55 | 0.00 | 24.99 | -450.68 |
| Quality | ||||
| ROIC | -31.95% | 3.03% | 3.18% | 9.22% |
| Gross Margin | 28.18% | 100.00% | 104.37% | 83.60% |
| Cash Conversion Ratio | -3.82 | -0.42 | -3.21 | 0.90 |
| Growth | ||||
| Revenue 3-Year CAGR | -10.98% | -17.36% | 8.31% | 23.80% |
| Free Cash Flow Growth | 100.00% | 91.35% | -232.40% | 346.03% |
| Safety | ||||
| Net Debt / EBITDA | -1.55 | 0.00 | 1.18 | -29.23 |
| Interest Coverage | 0.00 | 10.28 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.99 | 6.42 | 369.60 | -93.61 |